FDA staff raises eye damage concerns for GSK's blood cancer drugF
Continue reading...
FDA staff raises eye damage concerns for GSK’s blood cancer drug
FDA staff raises eye damage concerns for GSK's blood cancer drug
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that...
